Ionis Pharmaceuticals | IONS - PE Price to Earnings


Ionis Pharmaceuticals reported 396.15 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Arrowhead Research 39.19 2.48 Mar/2026
Astellas Pharma 9.41 6.06 Jun/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Exelixis 13.91 588.4 Mar/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Neurocrine Biosciences 22.1 5.99 Jun/2026
Novartis 22.41 2.24 Jun/2026
OPKO Health 40.77 7.86 Sep/2021
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pfizer 11.48 2.16 Jun/2026
Pharma Mar 16.35 2.78 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Qiagen NV 19.48 1.06 Mar/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Vertex Pharmaceuticals 28.05 2.22 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026